Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Nicholas James, MBBS, PhD, FRCP, FRCR, The Institute of Cancer Research, London, UK, shares his highlights from a session on practising beyond clinical trial data in urothelial cancer. Specifically, he discusses adjuvant chemotherapy and immuno-oncology. This interview was recorded at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.